Role of blue-light cystoscopy in the management of non-muscle invasive bladder cancer

被引：0
|
作者：
Pignot, G. [1 ]
机构：
[1] Univ Paris Sud, Hop Bicetre, Serv Urol, F-94270 Le Kremlin Bicetre, France
来源：
PROGRES EN UROLOGIE | 2015年 / 25卷 / 10期
关键词：
Non-muscle invasive bladder cancer; Cystoscopy; Diagnosis; Recurrence; Cost-effectiveness; Indications; GUIDED FLUORESCENCE CYSTOSCOPY; CARCINOMA IN-SITU; PHOTODYNAMIC DIAGNOSIS; COST-EFFECTIVENESS; FOLLOW-UP; COST/BENEFIT/THERAPEUTIC VALUE; TRANSURETHRAL RESECTION; FLEXIBLE CYSTOSCOPY; MUSCLE; RECURRENCE;
D O I：
10.1016/j.purol.2015.05.003
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Blue-light cystoscopy aims to facilitate the detection of bladder tumors in order to optimize the completeness of resection. We performed a literature analysis using data from Medline and according to PRISMA guidelines. Several meta-analyses have confirmed the interest of the blue-light cystoscopy in terms of improved detection rate and disease-free survival compared to standard white-light cystoscopy. These benefits outweigh the initial costs related to the acquisition of specific equipment, allowing an improvement in quality-adjusted life-years and a reduction of costs over time. Indications vary according to guidelines and must take into account equipment and logistic constraints on each center. The objective of this article is to make a focus on the role and the interest of blue-light cystoscopy in the management of NMIBC in 2015. (C) 2015 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：607 / 615
页数：9
相关论文
共 50 条
  • [21] Photodynamic versus white light-guided treatment of non-muscle invasive bladder cancer: a study protocol for a randomised trial of clinical and cost-effectiveness
    Tandogdu, Zafer
    Lewis, Rebecca
    Duncan, Anne
    Penegar, Steven
    McDonald, Alison
    Vale, Luke
    Shen, Jing
    Kelly, John D.
    Pickard, Robert
    N Dow, James
    Ramsay, Craig
    Mostafid, Hugh
    Mariappan, Paramananthan
    Nabi, Ghulam
    Creswell, Joanne
    Lazarowicz, Henry
    McGrath, John
    Taylor, Ernest
    Clark, Emma
    Maclennan, Graeme
    Norrie, John
    Hall, Emma
    Heer, Rakesh
    BMJ OPEN, 2019, 9 (09):
  • [22] Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer
    Lai, Lillian Y.
    Tafuri, Sean M.
    Ginier, Emily C.
    Herrel, Lindsey A.
    Dahm, Philipp
    Maisch, Philipp
    Lane, Giulia Ippolito
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (04):
  • [23] An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer
    Soria, Francesco
    Droller, Michael J.
    Lotan, Yair
    Gontero, Paolo
    D'Andrea, David
    Gust, Kilian M.
    Roupret, Morgan
    Babjuk, Marek
    Palou, Joan
    Shariat, Shahrokh F.
    WORLD JOURNAL OF UROLOGY, 2018, 36 (12) : 1981 - 1995
  • [24] THE ROLE OF REPEAT TRANSURETHRAL RESECTION IN THE MANAGEMENT OF NON-MUSCLE INVASIVE BLADDER CANCER
    Rolevich, A. I.
    Sukonko, O. G.
    Krasny, S. A.
    Strotsky, A. V.
    ONKOUROLOGIYA, 2010, 6 (01): : 59 - 64
  • [25] ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancer
    Monteiro, Leonardo L.
    Witjes, J. Alfred
    Agarwal, Piyush K.
    Anderson, Christopher B.
    Bivalacqua, Trinity J.
    Bochner, Bernard H.
    Boormans, Joost L.
    Chang, Sam S.
    Dominguez-Escrig, Jose L.
    McKiernan, James M.
    Dinney, Colin
    Godoy, Guilherme
    Kulkarni, Girish S.
    Mariappan, Paramananthan
    O'Donnell, Michael A.
    Rentsch, Cyrill A.
    Shah, Jay B.
    Solsona, Eduardo
    Svatek, Robert S.
    van der Heijden, Antoine G.
    van Valenberg, F. Johannes P.
    Kassouf, Wassim
    WORLD JOURNAL OF UROLOGY, 2019, 37 (01) : 51 - 60
  • [26] Blue versus white light for transurethral resection of non-muscle invasive bladder cancer (Review)
    Bellut, L.
    Kunath, F.
    UROLOGE, 2022, 61 (04): : 411 - 414
  • [27] Comparing CxBladder to Urine Cytology as Adjunct to Cystoscopy in Surveillance of Non-muscle Invasive Bladder Cancer-A Pilot Study
    Chai, C. A.
    Yeoh, W. S.
    Rajandram, R.
    Aung, K. P.
    Ong, T. A.
    Kuppusamy, S.
    Nazran, A.
    Kumaran, K.
    Razack, A. H. A.
    Teoh, J. Y.
    FRONTIERS IN SURGERY, 2021, 8
  • [28] Cost-effectiveness analysis of blue light cystoscopy with hexylaminolevulinate in transurethral resection of the bladder
    Gakis, G.
    Volkmer, B.
    Qvick, B.
    Marteau, F.
    Stenzl, A.
    UROLOGE, 2019, 58 (01): : 34 - 40
  • [29] Clinical and Cost Effectiveness of Hexaminolevulinate-guided Blue-light Cystoscopy: Evidence Review and Updated Expert Recommendations
    Witjes, J. Alfred
    Babjuk, Marek
    Gontero, Paolo
    Jacqmin, Didier
    Karl, Alexander
    Kruck, Stephan
    Mariappan, Paramananthan
    Redorta, Juan Palou
    Stenzl, Arnulf
    van Velthoven, Roland
    Zaak, Dirk
    EUROPEAN UROLOGY, 2014, 66 (05) : 863 - 871
  • [30] Considerations on the use of urine markers in the management of with high-grade non-muscle-invasive bladder cancer
    Kamat, Ashish M.
    Vlahou, Antonia
    Taylor, John A.
    Hudson, M'Liss A.
    Pesch, Beate
    Ingersoll, Molly A.
    Todenhoefer, Tilmann
    van Rhijn, Bas
    Kassouf, Wassim
    Grossman, H. Barton
    Behrens, Thomas
    Chandra, Ashish
    Goebell, Peter J.
    Palou, Juan
    Sanchez-Carbayo, Marta
    Schmitz-Draeger, Bernd J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (07) : 1069 - 1077
12345